Delivery Order SPE2DB25D3201-SPE2DB26FNNPH
Award Date 10/23/25
Potential Completion Date 11/14/25
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,953.30 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes, with a ceiling value of $2,325.55. This is a firm fixed-price delivery order without set-aside designation, reflecting a competitively awarded procurement. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $27,906.60. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $46,511 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes, with an ultimate completion date of September 25, 2025. This competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $23,255.50 delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on August 18, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and specifies performance at the contractor's location in Conshohocken, Pennsylvania. LEQVIO is an injectable cardiovascular medication used to lower LDL cholesterol levels, reflecting the Defense...
- The Defense Logistics Agency awarded a $9.3K delivery order to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 ml syringes on September 26, 2025, with completion targeted for October 20, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LEQVIO is a prescription medication used to lower cholesterol levels, and this delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $11,627.75 to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 mL syringes. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LEQVIO is a prescription medication used for cholesterol management, and the delivery order reflects the federal government's pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,255.50 to AmerisourceBergen Drug Corp for the supply of LEQVIO 284 mg/1.5 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 14, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in open federal...
- The U.S. Department of Defense's Medical Supply Chain awarded a $4,651.10 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of LEQVIO 284 mg/1.5 ml syringes. This competitively awarded, firm fixed-price contract is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the company's proven capability to compete in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,976.65 to AmerisourceBergen Drug Corp for LEQVIO 284 mg/1.5 mL syringes. This firm fixed-price, competitively awarded contract—with no set-aside designation—calls for delivery of the pharmaceutical product to the company's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. LEQVIO is a prescription medication used to treat high cholesterol in patients at risk for cardiovascular...